drugset / Trial / NCT02118519

Mesenchymal Stem Cells in Knee Cartilage Injuries

NCT02118519 ↗

Phase 2 Completed 13 enrolled University of Jordan
Non-randomizedParallel-groupDouble-blindTreatment

Summary

Induction of autologous repair chondrogenesis to regenerate injured articular cartilage using bone marrow mesenchymal stem cells (MSCs) after in vitro expansion under restricted culturing conditions.

Timeline

Start
2014-01
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Autologous mesenchymal stem cells Cell therapy — Other